Netlist (NLST) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales surged 267% year-over-year to $36.8 million, driven by strong operational performance and major legal victories, including nearly $750 million in damages awarded for patent infringement against Samsung and Micron.
The company remains focused on innovation in memory and storage, with ongoing investment in R&D and patent portfolio expansion.
Jury verdicts confirmed Samsung no longer holds a license to the company's patents, validating IP protection efforts and supporting long-term licensing objectives.
Ongoing legal actions and appeals are expected, with further exposure for infringing parties as product shipments increase.
Net loss for Q2 2024 was $14.8 million, with a gross profit of $0.8 million.
Financial highlights
Q2 2024 revenue reached $36.8 million, up from $10.0 million in Q2 2023; gross margin was approximately 2.1%.
Six-month net sales were $72.6 million, with a net loss of $31.7 million.
Cash, cash equivalents, and restricted cash totaled $36.4 million at quarter-end.
Inventory turn improved to 18x from 4x year-over-year; days in inventory dropped by 72 days to 21 days.
Working capital deficit was ($1.3) million as of June 29, 2024.
Outlook and guidance
Moderate revenue increase expected in Q3 2024, supported by bookings, shipments, and positive industry trends.
Legal costs anticipated to remain flat in Q3 and decrease by year-end.
Gross margin expected to improve in Q3 and Q4 due to better pricing and product mix, with target product margins around 5%-6%.
Management expects continued investment in R&D and legal expenses to protect and monetize the patent portfolio.
Existing cash, credit facilities, and equity lines are expected to be sufficient for at least the next 12 months.
Latest events from Netlist
- Q4 revenue soared 121% year-over-year as AI demand and memory shortages drove sharp price gains.NLST
Q4 20253 Mar 2026 - Q3 sales up 5% to $42.2M, net loss narrowed, but litigation and supply risks persist.NLST
Q3 20253 Feb 2026 - Q3 sales up 140% to $40.2M, net loss narrows, and major patent awards boost liquidity.NLST
Q3 202418 Jan 2026 - Revenue surged 113% in 2024, but losses and litigation risks remain high.NLST
Q4 202424 Dec 2025 - Up to $31 million in common stock may be sold to Lincoln Park Capital, with broad use of proceeds.NLST
Registration Filing16 Dec 2025 - Flexible $200M securities offering targets growth, IP monetization, and innovation in memory solutions.NLST
Registration Filing16 Dec 2025 - Offering 11M+ shares via warrant exercise at $3.20/share, with proceeds for general corporate use.NLST
Registration Filing16 Dec 2025 - Shareholders to vote on re-electing three directors and updated disclosures on ownership and transactions.NLST
Proxy Filing1 Dec 2025 - Annual Meeting to elect sole director and ratify new auditor, with all oversight by the sole director.NLST
Proxy Filing1 Dec 2025